Updates to the Mammography Quality Standards Act

30 March 2019 The US Food and Drug Administration (FDA) recently released a statement announcing amendments to the Mammography Quality Standards Act (MQSA). The “lay person letter” that patients receive with information about their mammogram results, and aspects of mammography facility quality measures, are part of the MQSA.  As noted in the FDA statement, proposed changes to current regulations include:…

Read more